Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06385184 · ClinicalTrials.gov registry record
Social & QoL Behaviors in Parkinson's Disease
A clinical trial of Parkinson Disease, sponsored by Gregory Wallace.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT06385184 is a study of Parkinson Disease that is actively recruiting participants, run by Gregory Wallace. The registered enrollment target is 500 participants, below the 5,325-participant average among 297 other Parkinson Disease trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06385184, a study of Parkinson Disease, is actively recruiting participants, sponsored by Gregory Wallace.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
Adults with Parkinson's Disease experience an array of challenges and changes in daily living, behaviors, and functioning throughout the progression of their condition. The investigators want to learn more about the effects of Parkinson's Disease on individuals' social behavior and quality of life (QoL) compared to people of the same age without Parkinson's Disease.
Conditions Studied
Interventions
- OTHER No Intervention
Study Locations (1)
District of Columbia
- The George Washington University - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2024-03-08 |
| Est. Completion | 2027-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06385184
The ClinicalTrials.gov registry entry for NCT06385184 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,325-participant average among 297 other Parkinson Disease trials with a reported enrollment target (91% lower). The listed sponsor is Gregory Wallace, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which No Intervention is the first listed.
NCT06385184 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.
Frequently Asked Questions
What is clinical trial NCT06385184 about?
NCT06385184 is a clinical study titled "Social & QoL Behaviors in Parkinson's Disease". Adults with Parkinson's Disease experience an array of challenges and changes in daily living, behaviors, and functioning throughout the progression of their condition. The investigators want to learn more about the effects of Parkinson's Disease on individuals' social behavior and quality of life (...
What is the current status of trial NCT06385184?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2024-03-08. Estimated completion is 2027-12-31.
What conditions does trial NCT06385184 study?
This clinical trial studies the following conditions: Parkinson Disease.
What interventions are being tested in trial NCT06385184?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT06385184?
This trial is sponsored by Gregory Wallace, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06385184 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis
RECRUITING
-
University of Delaware Parkinson's Disease Registry
RECRUITING
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.